
CAS 1899921-05-1
:HS-10296
Description:
As of my last update in October 2023, there is limited publicly available information regarding the chemical substance known as HS-10296, with the CAS number 1899921-05-1. This compound may be a specialized or proprietary chemical, potentially used in research or industrial applications. Typically, substances with such identifiers are characterized by their molecular structure, functional groups, solubility, stability, and reactivity, which can influence their behavior in various chemical environments. Additionally, safety data sheets (SDS) would provide crucial information regarding toxicity, handling, and storage requirements. For specific characteristics such as molecular weight, boiling point, melting point, and spectral data, consulting scientific literature or databases that specialize in chemical substances would be necessary. If HS-10296 is under investigation or development, details may be limited to proprietary information or ongoing research studies. Always refer to the latest scientific resources or databases for the most accurate and comprehensive information.
Formula:C30H35N7O2
Synonyms:- HS-10296;HS 10296;HS10296;1899921-05-1
- N-(5-((4-(1-Cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide
- 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-
- HS 10296;HS10296
- Almonertinib (HS-10296)
- N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(meth)amino)-4-methoxyphenyl)acrylamide
- Almonertinib
- HS-10296
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Almonertinib
CAS:<p>Almonertinib (HS-10296) is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M, which has only limited activity against wild-type EGFR.</p>Formula:C30H35N7O2Purity:99.99%Color and Shape:SolidMolecular weight:525.64HS-10296
CAS:<p>HS-10296 is a novel pharmaceutical compound that functions as a specific inhibitor of EGFR (epidermal growth factor receptor), which is a key therapeutic target in certain cancer pathways. This compound is derived from a synthetic source, meticulously designed to target and interrupt the signaling pathways involved in tumor proliferation and survival. The mode of action of HS-10296 involves the competitive inhibition of the ATP-binding domain of EGFR tyrosine kinase, thereby preventing phosphorylation and subsequent activation of downstream signaling proteins involved in cell division and survival.</p>Formula:C30H35N7O2Purity:Min. 95%Molecular weight:525.64 g/mol





